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Summary and Implications
Porcine colonic spirochetosis
(PCS) is a non-fatal, diarrheal disease
affecting pigs during the growing and

finishing stages of production. The
disease is caused by Serpulina pilosicoli,
a newly recognized species of intestinal spirochetes. Because Serpulina
pilosicoli is transmitted by the fecaloral route, control measures aimed at
reducing environmental contamination,
including sanitation and antimicrobial therapy, should be investigated.
We determined the antimicrobial susceptibility of seven porcine Serpulina
pilosicoli isolates recovered from pigs

in the midwestern United States against
four antimicrobials commonly used
for control of swine dysentery, a disease caused by the related spirochete,
Serpulina hyodysenteriae. All the isolates were susceptible to carbadox and
tiamulin, whereas the percentages of
isolates susceptible, intermediate and
resistant were 66.6, 16.6 and 16.6
percent with lincomycin, and 50 percent susceptible and 50 percent resis(Continued on next page)
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tant with gentamicin. This information is consistent with field observations about the efficacy of the respective antimicrobials for control of PCS.
Introduction
Porcine intestinal spirochetes
consist of at least three species in the
genus Serpulina; Serpulina hyodysenteriae, the agent of swine dysentery,
Serpulina innocens, a non-pathogenic
spirochete of the swine colon and the
newly recognized Serpulina pilosicoli,
the agent of porcine colonic spirochetosis (PCS). Clinical signs of Serpulina
pilosicoli infection consist of transientto-persistent watery to mucoid green
to cement gray cow-manure-like diarrhea without blood, usually occurring
10 to 14 days after mixing grower pigs
from different sources. While up to 50
percent of the pigs may show diarrhea,
morbidity varies greatly from farm to
farm and the factors responsible for
this variation are not completely understood. Although the diarrhea associated with PCS usually subsides, the
concurrent depression of weight gains
results in unevenness within affected
groups. This is a major problem in all
in/all out management systems in which
PCS causes disruption of pig flow by
both extending the marketing period
and increasing the number of pigs with
lighter weights.
Because transmission ofSerpulina
pilosicoli is by the fecal-oral route,
control measures aimed at reducing
environmental contamination, including sanitation and antimicrobial therapy,
should provide adequate disease control. Since Serpulina pilosicoli is a
newly identified intestinal spirochete,
determining the antimicrobial susceptibility of this organism so diseasespecific control strategies can be implemented is important. In this study, we
determined the antimicrobial susceptibility of seven porcine Serpulina
pilosicoli isolates against four antimicrobials commonly used to treat swine
dysentery. TheSerpulina pilosicoli were
isolated from pigs on farms in the
midwestern United States.
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Materials and Methods
A total of seven isolates ofSerpulina
pilosicoli were obtained from rectal
swabs or colonic scrapings taken from
pigs on farms in Iowa (n = 2), Missouri
(n = 3) and Nebraska (n = 1). All the
isolates were from different farms except isolates UNL-53 and UNL-54,
which were both obtained from one
farm in Missouri (Table 1). After isolating the spirochetes by anaerobic
culture on selective medium, representative isolates were characterized
using a polymerase chain reaction
amplification method specific for
Serpulina pilosicoli. The minimal inhibitory concentrations (MIC) of
carbadox, gentamicin, lincomycin and
tiamulin against theSerpulina pilosicoli
isolates were determined by an agardilution method.
Results
The MIC of carbadox, gentamicin, lincomycin and tiamulin against
each Serpulina pilosicoli isolate is presented in Table 1. Because isolates
UNL-53 and UNL-54 were obtained

from the same farm and had the same
MIC values, they were considered one
for the calculations of the MIC of each
antimicrobial effective against 50 percent (MIC50) and 90 percent (MIC 90) of
the isolates (Table 2). From available
literature data on the antimicrobial
susceptibility breakpoints of Serpulina
hyodysenteriae for each antimicrobial,
we estimated all of the Serpulina
pilosicoli isolates were susceptible to
carbadox and tiamulin. However, the
percentages of isolates susceptible,
intermediate and resistant were 66.6,
16.6 and 16.6 percent with lincomycin, and 50 percent susceptible and 50
percent resistant with gentamicin.
Discussion
The results from this study indicate the pattern of antimicrobial susceptibility of midwestern porcine
Serpulina pilosicoli to antimicrobials
used for treatment of swine dysentery
was similar to that of Serpulina
hyodysenteriae. Because of this, control measures known to be effective for
swine dysentery, including stress reduction, sanitation and medication of

µg/ml) of four antimicrobials againstSerpulina
Table 1. Minimal inhibitory concentration values (µ
pilosicoli isolated from pigs on farms in the midwestern United States
Isolate

Origin†

UNL-5
B1555a
UNL-53
UNL-54
UNL-55
B359
UNL-8

Iowa
Iowa
Missouri
Missouri
Missouri
Missouri
Nebraska

Carbadox
<0.0005
<0.0005
0.015
0.015
0.005
<0.0005
0.005

Gentamicin

Lincomycin

1.0
1.0
10.0
10.0
10.0
1.0
10.0

25.0
12.5
75.0
75.0
25.0
12.5
50.0

Tiamulin
0.50
0.05
0.10
0.10
0.05
0.20
0.05

†All isolates are from different farms except for isolates UNL-53 and UNL-54 which are from the same farm.

Table 2. Minimal inhibitory concentration (MIC) values of four antimicrobials againstSerpulina
pilosicoli isolates obtained from pigs on farms in the midwestern United States
Antimicrobial

Carbadox
Gentamicin
Lincomycin
Tiamulin

Drug concentration
range (µg/ml)
<0.0005 - 0.015
1.0 - 10.0
12.5 - 75.0
0.05 - 0.50

MIC

50

<0.0005

MIC

0.015
1.0
25.0
0.05

90

10.0
75.0
0.50

water and feed with Serpulina
hyodysenteriae-specific antimicrobials
should be effective against PCS caused
by Serpulina pilosicoli.
Koch’s postulates for Serpulina
pilosicoli have been fulfilled using
gnotobiotic pigs and conventional pigs.
Following initial association with the
cecal and colonic mucus gel, the spirochetes attach to the colonic enterocytes,
residing in the brush border of the
colonic cells where they damage the
microvilli, causing reduced surface area
and perhaps loss of absorptive function. Clinical signs of absorption failure or diarrhea may be seen when the
reserve capacity of the large intestine
is compromised sufficiently. With time,
the disease progresses to a stage in
which the balance between infection
and host response determines whether
the pig remains persistently infected
or eliminates the spirochetes. Pigs persistently infected with Serpulina
pilosicoli develop chronic inflammation of the large intestine. The following altered intestinal function is thought
to result in reduced growth rate.
Serpulina pilosicoli can be isolated from the large intestine of challenge-inoculated pigs for up to six
weeks post-inoculation, even though
diarrhea may have ceased. This suggests transmission of PCS is from shedding of Serpulina pilosicoli in the feces of persistently infected pigs. Some
pigs infected with Serpulina pilosicoli
may recover naturally without medication, but they have reduced average
body weight gain when compared with
noninfected control pigs. Carrier-shredder pigs are an important reservoir of
Serpulina pilosicoli on infected farms
and the movement of these pigs is the
most likely means of transmission of
Serpulina pilosicoli between farms.

Management systems favoring fecaloral recycling, such as open-flush gutters and recycled lagoon water, appear
to promote maintenance and transmission of PCS. Thus, in all in/all out
multi-site production systems, transmission is most likely from co-mingling susceptible and carrier-shredder
pigs or from the contaminated environment. In continuous flow production systems, spirochetes are most likely
transmitted when younger Serpulina
pilosicoli-naive pigs come into contact with feces of older pigs. The possibility also exists that hosts other than
pigs, such as dogs, rodents and wildlife, including birds, act as sources of
PCS infection, emphasizing the need
for biosecurity.
Diarrheal disease and reduced
performance associated withSerpulina
pilosicoli have been reported from all
major swine producing countries in
North America, Europe and Australia.
We estimated a 50 percent prevalence
rate of Serpulina pilosicoli infection
in finisher facilities within a multi-site
production system in the United States;
a finding not unlike the prevalence of
Serpulina hyodysenteriae several years
ago, before control measure for this
spirochete became widely available.
The results of antimicrobial susceptibility of midwestern isolates of
porcine Serpulina pilosicoli suggested
carbadox and tiamulin may be suitable
for control of PCS. Conversely, the
susceptibility of the isolates to lincomycin and gentamicin was variable.
Although field information is consistent with these laboratory results, the
applicability of specific antimicrobials in controlled challenge studies would
be helpful in making cost-effective recommendations for prevention or treatment of PCS. When response to treat-

ment is poor, (I) error in dosage and/or
inadequate delivery of antimicrobials,
(ii) combination of agents with different antimicrobial susceptibility or (iii)
poor control of environmental contamination may be involved. Eradication of Serpulina pilosicoli with antimicrobial therapy and sanitation with
or without depopulation is probably
possible, but it might not be cost-effective. When PCS occurs concurrently
with other cause(s) of diarrhea, such as
viruses, other bacteria, intestinal
parasites or other non-infectious
causes, mortality is high. In these cases,
thorough laboratory diagnostic investigation is needed in order to achieve
adequate control.
It is known that Serpulina pilosicoli has a broader host range than
Serpulina hyodysenteriae. Spirochetes similar to Serpulina pilosicoli
have been seen in the intestines of
humans, non-human primates, dogs,
guinea pigs, opossums, mice and birds
often with clinical signs or lesions
of colonic spirochetosis. Because
Serpulina pilosicoli has been isolated
from humans with lesions similar to
PCS and human Serpulina pilosicoli
can colonize in pigs and produce
colitis, it may be zoonotic and have
public health significance.
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